If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
106.50    0.50 (0.47%)
Bid:
104.00
Ask:
109.00
Spread: 5.00 (4.808%)
Market Cap: £64.07m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Launch of latest version of MyID PIV

15 Jul 2010 07:00

RNS Number : 3747P
Intercede Group PLC
15 July 2010
 



 

Intercede Group plc

("Intercede" or the "Company")

 

Intercede Announces the Most Comprehensive Software Platform for PIV, PIV-I and PIV-C Identity and Credential Management Projects

Highlights:

·; Latest version of MyID PIV now available - MyID PIV 8 SR1

·; Based on the most recent PIV Standards

·; Levers MyID's interoperability to exploit convergence between Federal and non-Federal identity and credential management projects

·; Proven Deployments

 

London, United Kingdom, 15 July 2010 - Intercede (London Stock Exchange AIM: IGP) today announced the release of MyID PIV Version 8 Service Release 1 (SR1) for US Federal, State and Local Government. This latest version of MyID PIV supports the most recent Federal Information Processing Standard 201 (FIPS 201) updates and is in use and available today.

Intercede already has more than 10 US Federal Government Agencies already using MyID PIV 8 and we anticipate that most of these customers will be contracting to upgrade to the new SR1 version over the coming months. The benefit to Agencies is that SR1 will enable them to maintain compliance with the recently modified SP800-73-3 standard as well as facilitating the use of the latest Microsoft platforms.

MyID PIV 8 SR1 also builds on Intercede's substantial experience in supporting non-Federal customers who need to issue identity credentials that are interoperable with the US Federal PIV systems (PIV-I). The programs include Transportation Worker Identity Credential (TWIC), First Responder Authentication Credential (FRAC) and Airport Credentials Interoperability Solution (ACIS). Intercede has already won the TWIC system, has secured a growing number of early FRAC deployments and anticipates participating in the ACIS program.

In addition, MyID PIV 8 SR1 supports private sector US government contractor organisations that wish to benefit from issuing credentials that are compatible with PIV compliant security hardware and electronic card content . These solutions are termed PIV compatible (PIV-C). Intercede is already supplying PIV-C solutions to Lockheed Martin (150,000 employees) and a major US government integrator/consultancy group in the DC area. Intercede anticipates deploying PIV-C to other major customers later this year.

MyID PIV was the first card management system to be listed on the FIPS 201 approved products list and is the only PIV identity and credential management platform that provides a single point for registration, identity checking/vetting, issuance, lifecycle management and auditing/reporting. Two of the key advantages which are unique to MyID PIV are a single point of revocation for PIV identity cards and other credentials (e.g. RSA SecureID tokens) and a single point of auditing and reporting across all stages (registration, identity checking/vetting and issuance) of the PIV card lifecycle. 

What's New in MyID 8 PIV SR1

·; Support for PIV-I and PIV-C

·; Support for the latest standards for PIV, PIV-I and PIV-C (SP800-73-3)

·; Automatic on-card recovery of up to 20 historical encryption certificates

·; Support for the next generation PIV Cards including Oberthur, Gemalto, G&D and SafeNet

·; Usability Enhancements for PIV, PIV-I and PIV-C

·; Extended Microsoft Platform Support

Intercede President and Chief Executive, Richard Parris said, "This latest update to the MyID software platform continues Intercede's momentum as the premium supplier of PIV management systems to the US government and related markets. While our competitors have been talking about their aspirations in these sectors, Intercede has been steadily securing market share by delivering quality products and services that enable our customers to meet their program plans. As the next wave of PIV procurements commences, both inside and outside of government, Intercede is well positioned to extend existing deployments and to win business from new federal, state and private customers".

About Intercede

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalisation, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include more than 10 Federal Agencies, a program with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

For more information visit www.intercede.com

###

ENQUIRIES

Intercede Group plc Richard Parris, Chairman & Chief Executive Andrew Walker, Finance Director Tel. +44 (0)1455 558111

finnCap Clive Carver, Corporate Finance Joanna Weaving, Corporate Broking Tel. +44 (0)20 7600 1768

Pelham Bell Pottinger, Public Relations Archie Berens/Francesca Tuckett Tel. +44 (0)20 7861 3112

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADZLFFBDFFBBZ
Date   Source Headline
23rd Jun 20267:00 amRNSFinal Results
15th Jun 20267:00 amRNS-RExtension of Partnership with Swissbit
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.